🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 16 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/01/2002 | 4,75 | 4,87 | 4,63 | 4,71 | -0,95% | 5,05% | 214.800 |
| 14/01/2002 | 4,75 | 4,88 | 4,73 | 4,75 | -0,52% | 3,05% | 163.800 |
| 11/01/2002 | 4,93 | 4,94 | 4,76 | 4,78 | -2,75% | 3,55% | 359.200 |
| 10/01/2002 | 4,90 | 4,96 | 4,85 | 4,91 | +0,41% | 2,25% | 75.200 |
| 09/01/2002 | 5,06 | 5,10 | 4,88 | 4,89 | -2,78% | 4,35% | 239.800 |
| 08/01/2002 | 4,92 | 5,06 | 4,92 | 5,03 | +1,31% | 2,95% | 200.600 |
| 07/01/2002 | 5,01 | 5,13 | 4,87 | 4,97 | -1,59% | 5,09% | 465.000 |
| 04/01/2002 | 5,10 | 5,15 | 5,02 | 5,05 | -1,08% | 2,55% | 436.000 |
| 03/01/2002 | 5,19 | 5,20 | 5,01 | 5,10 | -0,49% | 3,76% | 419.600 |
| 02/01/2002 | 5,25 | 5,25 | 4,89 | 5,13 | -1,54% | 6,95% | 380.400 |
| 31/12/2001 | 5,18 | 5,33 | 5,08 | 5,21 | +0,87% | 4,92% | 348.000 |
| 28/12/2001 | 5,15 | 5,26 | 5,08 | 5,16 | +1,38% | 3,59% | 569.000 |
| 27/12/2001 | 5,03 | 5,10 | 5,00 | 5,09 | +2,00% | 1,99% | 302.200 |
| 26/12/2001 | 4,93 | 5,07 | 4,93 | 4,99 | +0,50% | 2,84% | 508.000 |
| 24/12/2001 | 5,08 | 5,18 | 4,90 | 4,97 | -2,17% | 5,42% | 442.200 |
| 21/12/2001 | 4,95 | 5,20 | 4,95 | 5,08 | +2,32% | 4,95% | 1.257.600 |
| 20/12/2001 | 5,18 | 5,20 | 4,86 | 4,96 | -2,65% | 6,67% | 541.200 |
| 19/12/2001 | 5,15 | 5,35 | 5,08 | 5,10 | -2,02% | 5,24% | 1.109.400 |
| 18/12/2001 | 4,71 | 5,30 | 4,65 | 5,20 | +10,64% | 13,82% | 3.039.800 |
| 17/12/2001 | 4,60 | 4,75 | 4,58 | 4,70 | +2,17% | 3,70% | 444.200 |
| 14/12/2001 | 4,47 | 4,83 | 4,38 | 4,60 | +2,22% | 9,97% | 604.000 |
| 13/12/2001 | 4,53 | 4,58 | 4,42 | 4,50 | -1,10% | 3,54% | 586.800 |
| 12/12/2001 | 4,53 | 4,63 | 4,48 | 4,55 | +0,11% | 3,31% | 525.000 |
| 11/12/2001 | 4,40 | 4,55 | 4,28 | 4,55 | +3,77% | 6,25% | 842.200 |
| 10/12/2001 | 4,44 | 4,50 | 4,38 | 4,38 | -2,34% | 2,71% | 234.800 |
| 07/12/2001 | 4,48 | 4,54 | 4,43 | 4,49 | -0,33% | 2,57% | 253.000 |
| 06/12/2001 | 4,51 | 4,55 | 4,43 | 4,50 | -0,11% | 2,55% | 273.400 |
| 05/12/2001 | 4,55 | 4,55 | 4,43 | 4,51 | +0,00% | 2,64% | 387.600 |
| 04/12/2001 | 4,58 | 4,59 | 4,47 | 4,51 | -1,53% | 2,62% | 257.400 |
| 03/12/2001 | 4,50 | 4,63 | 4,49 | 4,58 | +1,67% | 3,11% | 283.000 |